Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 27 Sep 2022

Prescription medication use of United States military service members by therapeutic classification

in Pharmacoepidemiology

Joseph J. Knapik
Daniel W. Trone
Ryan A. Steelman
Emily K. Farina
Harris R. Lieberman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.972031

10,388 views
5 citations

Original Research

Published on 26 Sep 2022

Association between antibiotics and dementia risk: A retrospective cohort study

in Pharmacoepidemiology

Minseo Kim
Sun Jae Park
Seulggie Choi
Jooyoung Chang
Sung Min Kim
Seogsong Jeong
Young Jun Park
Gyeongsil Lee
Joung Sik Son
Joseph C. Ahn

Frontiers in Pharmacology

doi 10.3389/fphar.2022.888333

16,510 views
38 citations

Original Research

Published on 20 Sep 2022

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

in Pharmacoepidemiology

Luiza Hoehl Loureiro Alves Barbosa
Alice Ramos Oliveira Silva
Ana Paula D’Alincourt Carvalho-Assef
Elisangela Costa Lima
Fabricio Alves Barbosa da Silva

Frontiers in Pharmacology

doi 10.3389/fphar.2022.948339

5,229 views
3 citations

Original Research

Published on 16 Sep 2022

Role of daytime variation in pharmaceutical effects of sufentanil, dezocine, and tramadol: A matched observational study

in Pharmacoepidemiology

Wanxia Gan
Xinqing Yang
Jie Chen
Hongyao Lyu
Ai Yan
Guizhen Chen
Shiqi Li
Yamei Zhang
Ling Dan
He Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993506

3,859 views
4 citations

Original Research

Published on 15 Sep 2022

An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project

in Pharmacoepidemiology

Valeria Belleudi
Alessandro C. Rosa
Marco Finocchietti
Francesca R. Poggi
Maria Lucia Marino
Marco Massari
Stefania Spila Alegiani
Lucia Masiero
Andrea Ricci
Gaia Bedeschi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.959267

4,028 views
15 citations

Original Research

Published on 14 Sep 2022

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients

in Pharmacoepidemiology

Akihiko Nishimura
Junqing Xie
Kristin Kostka
Talita Duarte-Salles
Sergio Fernández Bertolín
María Aragón
Clair Blacketer
Azza Shoaibi
Scott L. DuVall
Kristine Lynch

Frontiers in Pharmacology

doi 10.3389/fphar.2022.945592

4,803 views
4 citations

Original Research

Published on 13 Sep 2022

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease

in Pharmacoepidemiology

Yong-Li Gu
Zeng-Xian Sun
Ying Sun
Yan Wen
Xin Guan
Dao-Li Jiang
Cong Cheng
Huan Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.892526

3,442 views
2 citations

Original Research

Published on 13 Sep 2022

Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study

in Pharmacoepidemiology

Yen-Chieh Lee
Yaa-Hui Dong
Wei-Shun Yang
Li-Chiu Wu
Jou-Wei Lin
Chia-Hsuin Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.869804

3,942 views
5 citations

Original Research

Published on 07 Sep 2022

Trends in the utilization of psychotropic medications in China from 2018 to 2021

in Pharmacoepidemiology

Xinyan Zhang
Xiaowen Hu
Yuxuan Zhao
Christine Y. Lu
Xiaoyan Nie
Luwen Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967826

6,598 views
16 citations

Original Research

Published on 06 Sep 2022

Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database

in Pharmacoepidemiology

Yamin Shu
Qilin Zhang
Xucheng He
Yanxin Liu
Pan Wu
Li Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.990241

49,705 views
53 citations

Original Research

Published on 06 Sep 2022

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed

in Pharmacoepidemiology

Kristjan Linnet
Heidrun Sjofn Thorsteinsdottir
Johann Agust Sigurdsson
Emil Larus Sigurdsson
Larus Steinthor Gudmundsson

Frontiers in Pharmacology

doi 10.3389/fphar.2022.932380

4,233 views
4 citations

Clinical Trial

Published on 05 Sep 2022

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale

in Pharmacoepidemiology

Nicolas Kerckhove
Noémie Delage
Célian Bertin
Emmanuelle Kuhn
Nathalie Cantagrel
Caroline Vigneau
Jessica Delorme
Céline Lambert
Bruno Pereira
Chouki Chenaf

Frontiers in Pharmacology

doi 10.3389/fphar.2022.947006

4,397 views
10 citations

Review

Published on 25 Aug 2022

Immune-related adverse events of biological immunotherapies used in COVID-19

in Pharmacoepidemiology

Daniela Baracaldo-Santamaría
Giovanna María Barros-Arias
Felipe Hernández-Guerrero
Alejandra De-La-Torre
Carlos-Alberto Calderon-Ospina

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973246

4,957 views
5 citations

Methods

Published on 23 Aug 2022

Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data

in Pharmacoepidemiology

Odile Sauzet
Victoria Cornelius

Frontiers in Pharmacology

doi 10.3389/fphar.2022.889088

3,217 views
10 citations

Original Research

Published on 22 Aug 2022

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease

in Pharmacoepidemiology

Fu-Shun Yen
James Cheng-Chung Wei
Lu-Ting Chiu
Chih-Cheng Hsu
Chii-Min Hwu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.919881

5,657 views
5 citations

Brief Research Report

Published on 17 Aug 2022

Anti-NMDA receptor encephalitis and vaccination: A disproportionality analysis

in Pharmacoepidemiology

Salomé Martin
Brahim Azzouz
Aurore Morel
Thierry Trenque

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940780

7,649 views
8 citations

Systematic Review

Published on 11 Aug 2022

Safety of biological therapy in patients with rheumatoid arthritis in administrative health databases: A systematic review and meta-analysis

in Pharmacoepidemiology

Mariana Jorge de Queiroz
Caroline Tianeze de Castro
Flavia Caixeta Albuquerque
Celmário Castro Brandão
Leticia Farias Gerlack
Daniella Cristina Rodrigues Pereira
Sandra Castro Barros
Wenderson Walla Andrade
Ediane de Assis Bastos
Jessé de Nobrega Batista Azevedo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928471

8,359 views
8 citations

Systematic Review

Published on 11 Aug 2022

Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis

in Pharmacoepidemiology

Caroline Tianeze de Castro
Mariana Jorge de Queiroz
Flavia Caixeta Albuquerque
Celmário Castro Brandão
Leticia Farias Gerlack
Daniella Cristina Rodrigues Pereira
Sandra Castro Barros
Wenderson Walla Andrade
Ediane de Assis Bastos
Jessé de Nobrega Batista Azevedo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.927179

14,765 views
21 citations

Original Research

Published on 08 Aug 2022

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

in Pharmacoepidemiology

Ioana Frent
Daniel Leucuta
Camelia Bucsa
Andreea Farcas
Florin Casoinic
Cristina Mogosan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.925805

4,659 views
3 citations

Systematic Review

Published on 05 Aug 2022

Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

in Pharmacoepidemiology

Dan Ouyang
Yuan Zhi Ma
Jie Zou
Yong Long Wang
Zheng Chen
Yu Ying Yang
Bin Zou
Xin Li
Jian Zhong Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.911810

6,704 views
12 citations

Opinion

Published on 26 Jul 2022

Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts

in Pharmacoepidemiology

Patrick Maison
Mahmoud Zureik
Virginie Hivert
Jesper Kjaer
Roman Hossein Khonsari
Gianluca Trifirõ
Christelle Ratignier-Carbonneil

Frontiers in Pharmacology

doi 10.3389/fphar.2022.969091

5,113 views
2 citations

Protocols

Published on 22 Jul 2022

The Use of the Target Trial Approach in Perinatal Pharmacoepidemiology: A Scoping Review Protocol

in Pharmacoepidemiology

Lisiane Freitas Leal
Sonia Marzia Grandi
Daniel Marques Mota
Paulo José Gonçalves Ferreira
Genevieve Gore
Robert William Platt

Frontiers in Pharmacology

doi 10.3389/fphar.2022.904824

5,536 views
2 citations

Original Research

Published on 22 Jul 2022

The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study

in Pharmacoepidemiology

Ruiqiu Zhang
Yanxin Liu
Jia Cao
Jiahui Lao
Baobao Wang
Siwen Li
Xin Huang
Fang Tang
Xiao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.924173

9,745 views
17 citations

Original Research

Published on 22 Jul 2022

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system

in Pharmacoepidemiology

Eugene Jeong
Scott D. Nelson
Yu Su
Bradley Malin
Lang Li
You Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.938552

7,383 views
11 citations

601 articles

articles

Prescription medication use of United States military service members by therapeutic classification

Association between antibiotics and dementia risk: A retrospective cohort study

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

Role of daytime variation in pharmaceutical effects of sufentanil, dezocine, and tramadol: A matched observational study

An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease

Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study

Trends in the utilization of psychotropic medications in China from 2018 to 2021

Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale

Immune-related adverse events of biological immunotherapies used in COVID-19

Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease

Anti-NMDA receptor encephalitis and vaccination: A disproportionality analysis

Safety of biological therapy in patients with rheumatoid arthritis in administrative health databases: A systematic review and meta-analysis

Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts

The Use of the Target Trial Approach in Perinatal Pharmacoepidemiology: A Scoping Review Protocol

The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system